GLP Global Partners LP Common Units representing Limited Partner Interests
$49.89
Price · May 20, 2026
Fundamentals as of May 8, 2026
52W Range
$40–$57
61% of range
Analyst Rating
HOLD
9 analysts
Price Target
$46
P/E (TTM)
—
ROE
—
Net Profit Margin
0.53%
GLP Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$49.89
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
$18.56B
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$40 – $57
GLP Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$18.56B
2016-12-31
→
2025-12-31
EPS
—
Free Cash Flow
$193M
2016-12-31
→
2025-12-31
Margins
0.53%
2016-12-31
→
2025-12-31
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
GLP
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
GLP
Peer Median
Gross Margin
5.7%
37.8%
Operating Margin
1.3%
—
Net Profit Margin
0.53%
3.2%
ROA
2.6%
3.0%
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
GLP
Peer Median
Current Ratio
1.1
1.1
Quick Ratio
0.5
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
GLP
Peer Median
Revenue YoY
8.1%
—
Revenue CAGR 3Y
-0.56%
—
Revenue CAGR 5Y
17.4%
—
Net Income YoY
-11.2%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
GLP
Peer Median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
Dividend Yield
—
Payout Ratio
—
5Y Div CAGR
—
| Ex-date | Amount |
|---|---|
| May 11, 2026 | $0.7650 |
| Feb. 9, 2026 | $0.7600 |
| Nov. 10, 2025 | $0.7550 |
| Aug. 8, 2025 | $0.7500 |
| May 9, 2025 | $0.7450 |
| Feb. 10, 2025 | $0.7400 |
| Nov. 8, 2024 | $0.7300 |
| Aug. 8, 2024 | $0.7200 |
| May 8, 2024 | $0.7100 |
| Feb. 7, 2024 | $0.7000 |
| Nov. 7, 2023 | $0.6850 |
| Aug. 7, 2023 | $0.6750 |
| May 8, 2023 | $0.6550 |
| Feb. 7, 2023 | $1.5730 |
| Nov. 7, 2022 | $0.6250 |
| Aug. 5, 2022 | $0.6050 |
| May 6, 2022 | $0.5950 |
| Feb. 7, 2022 | $0.5850 |
| Nov. 5, 2021 | $0.5750 |
| Aug. 6, 2021 | $0.5750 |
GLP Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
SELL
9 analysts
- Strong Buy 0 0.0%
- Buy 0 0.0%
- Hold 4 44.4%
- Sell 4 44.4%
- Strong Sell 1 11.1%
12-Month Price Target
2 analysts · 2026-05-16
Median
$45.50
Above all targets →
$49.89
Low
$45.00
High
$46.00
Median target
$45.50
-8.8%
Mean target
$45.50
-8.8%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.29%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $1.85 | $0.33 | 1.5% |
| Dec. 31, 2025 | $0.54 | $0.61 | -0.07% |
| Sept. 30, 2025 | $0.66 | $1.10 | -0.44% |
| June 30, 2025 | $0.64 | $0.61 | 0.03% |
| March 31, 2025 | $0.36 | $-0.03 | 0.39% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| GLP | — | — | 8.1% | 0.53% | — | 5.7% |
| DKL | — | — | 7.7% | 17.4% | — | — |
| NEXT | — | -4.5 | — | — | -181.7% | — |
| NGL | — | — | -16.5% | 1.1% | — | — |
| LPG | $955M | 10.4 | -37.0% | 25.5% | 8.5% | — |
| GEL | — | -3.7 | -1.8% | -27.0% | — | — |
| CAPL | — | 20.2 | -10.6% | 1.1% | — | 11.0% |
| SMC | $327M | -16.6 | 30.8% | -1.1% | -1.2% | — |
| OSG | $350M | -1.3 | 6.5% | -103.1% | -34.2% | — |
| SMC | $327M | -16.6 | 30.8% | -1.1% | -1.2% | — |
| WMB | — | 28.1 | 13.8% | 21.9% | 20.7% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 11
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.56B | $17.16B | $16.49B | $18.88B | $13.25B | $8.32B | $13.08B | $12.67B | $8.92B | $8.24B | $10.31B | $17.27B | |
| Cost of Revenue | $17.50B | $16.11B | $15.52B | $17.78B | $12.53B | $7.60B | $12.42B | $12.02B | $8.34B | $7.69B | $9.72B | $16.73B | |
| Gross Profit | $1.06B | $1.06B | $974M | $1.10B | $719M | $721M | $663M | $650M | $583M | $546M | $598M | $545M | |
| SG&A Expense | $306M | $292M | $274M | $263M | $213M | $193M | $171M | $171M | $155M | $150M | $177M | $154M | |
| Operating Expenses | $827M | $807M | $730M | $637M | $577M | $529M | $524M | $453M | $463M | $699M | $483M | $379M | |
| Operating Income | $235M | $251M | $244M | $460M | $142M | $192M | $139M | $197M | $120M | $-152M | $115M | $166M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $73M | $48M | |
| Pretax Income | $99M | $115M | $161M | $379M | $62M | $102M | $36M | $108M | $34M | $-239M | $41M | $118M | |
| Income Tax | $1M | $5M | $8M | $17M | $1M | $-119.0K | $1M | $6M | $-24M | $53.0K | $-2M | $963.0K | |
| Net Income | $98M | $110M | $153M | $362M | $61M | $102M | $36M | $104M | $59M | $-199M | $44M | $117M | |
| EBITDA | $235M | $251M | $244M | $460M | $142M | $192M | $139M | $197M | $120M | $-152M | $115M | $252M |
Balance Sheet 21
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | · | $15M | $10M | $1M | $5M | |
| Receivables | $530M | $473M | $552M | $479M | $411M | $227M | $413M | $335M | $417M | $421M | $311M | $458M | |
| Inventory | $549M | $594M | $397M | $567M | $510M | $384M | $450M | $386M | $351M | $522M | $389M | $337M | |
| Prepaid Expense | $98M | $92M | $91M | $74M | $87M | $119M | $82M | $99M | $78M | $70M | $66M | $54M | |
| Current Assets | $1.23B | $1.21B | $1.10B | $1.17B | $1.07B | $781M | $1.00B | $875M | $878M | $1.08B | $867M | $959M | |
| PP&E (Net) | $1.66B | $1.71B | $1.51B | $1.22B | $1.10B | $1.08B | $1.10B | $1.13B | $1.04B | $1.10B | $1.24B | $825M | |
| PP&E (Gross) | $2.90B | $2.82B | $2.52B | $2.13B | $1.94B | $1.83B | $1.79B | $1.73B | $1.55B | $1.54B | $1.57B | $1.06B | |
| Accum. Depreciation | $1.24B | $1.11B | $1.01B | $910M | $840M | $751M | $683M | $595M | $514M | $436M | $327M | $231M | |
| Goodwill | $422M | $422M | $429M | $428M | $328M | $324M | $324M | $327M | $312M | $295M | $435M | $154M | |
| Intangibles | $13M | $19M | $21M | $27M | $26M | $36M | $47M | $59M | $57M | $65M | $76M | $49M | |
| Other Non-current Assets | $38M | $39M | $38M | $31M | $32M | $27M | $31M | $31M | $36M | $29M | $43M | $44M | |
| Total Assets | $3.85B | $3.79B | $3.45B | $3.16B | $2.83B | $2.54B | $2.81B | $2.42B | $2.32B | $2.56B | $2.66B | $2.03B | |
| Accounts Payable | $573M | $510M | $649M | $531M | $353M | $208M | $373M | $309M | $313M | $320M | $304M | $457M | |
| Accrued Liabilities | $208M | $223M | $180M | $157M | $139M | $127M | $103M | $117M | $100M | $70M | $60M | $83M | |
| Current Liabilities | $1.08B | $1.00B | $983M | $971M | $840M | $498M | $754M | $583M | $669M | $799M | $595M | $707M | |
| Capital Leases | $311M | $252M | $200M | $231M | $228M | $227M | $239M | · | · | · | · | · | |
| Deferred Tax | $65M | $64M | $69M | $66M | $57M | $56M | $43M | $43M | $40M | $66M | $85M | $13M | |
| Other Non-current Liabilities | $70M | $77M | $61M | $57M | $53M | $59M | $52M | $58M | $56M | $65M | $57M | $46M | |
| Total Liabilities | $3.18B | $3.07B | $2.65B | $2.37B | $2.30B | $2.05B | $2.35B | $1.93B | $1.93B | $2.17B | $1.97B | $1.39B | |
| AOCI | · | · | $381.0K | $-449.0K | $-2M | $2M | $-5M | $-5M | $-5M | $-5M | $-8M | $-13M | |
| Liabilities + Equity | $3.85B | $3.79B | $3.45B | $3.16B | $2.83B | $2.54B | $2.81B | $2.42B | $2.32B | $2.56B | $2.66B | $2.03B |
Cash Flow 14
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $86M | |
| Stock-based Comp | $13M | $15M | $11M | $3M | $707.0K | $1M | $2M | $3M | $3M | $4M | $4M | $3M | |
| Deferred Tax | $986.0K | $-5M | $3M | $10M | $599.0K | $13M | $23.0K | $3M | $-26M | $-19M | $-4M | $-11.0K | |
| Amort. of Intangibles | $5M | $8M | $8M | $9M | $11M | $11M | $11M | $11M | $9M | $9M | $13M | $19M | |
| Operating Cash Flow | $285M | $32M | $512M | $480M | $50M | $313M | $94M | $169M | $348M | $-120M | $63M | $345M | |
| CapEx | $91M | $103M | $89M | $107M | $102M | $76M | $83M | $69M | $50M | $71M | $93M | $95M | |
| Investing Cash Flow | $-101M | $-277M | $-492M | $-236M | $-115M | $-70M | $-67M | $-226M | $-62M | $6M | $-650M | · | |
| Stock Repurchased | $10M | $14M | $4M | $3M | $4M | $291.0K | · | · | · | · | $4M | $9M | |
| Net Stock Activity | $-10M | $-14M | $-4M | $-3M | $-4M | $-291.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $-180M | $234M | $-4M | $-251M | $66M | $-245M | $-23M | $50M | $-282M | $122M | $583M | · | |
| Net Change in Cash | $4M | $-11M | $16M | $-7M | $1M | $-2M | $4M | $-7M | $5M | $9M | $-4M | $-4M | |
| Taxes Paid | $6M | $9M | $3M | $8M | $-15M | $-1M | $-5M | $653.0K | $7M | · | · | · | |
| Free Cash Flow | $193M | $-72M | $424M | $373M | $-51M | $236M | $12M | $100M | $299M | $-191M | $-30M | $250M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | $-107M | $202M |
Profitability 6
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 5.7% | 6.2% | 5.9% | 5.8% | 5.4% | 8.7% | 5.1% | 5.1% | 6.5% | 6.6% | 5.8% | 3.1% | |
| Operating Margin | 1.3% | 1.5% | 1.5% | 2.4% | 1.1% | 2.3% | 1.1% | 1.6% | 1.3% | -1.8% | 1.1% | 0.96% | |
| Net Margin | 0.53% | 0.64% | 0.92% | 1.9% | 0.46% | 1.2% | 0.27% | 0.82% | 0.66% | -2.9% | 0.42% | · | |
| Pretax Margin | 0.53% | 0.67% | 0.97% | 2.0% | 0.47% | 1.2% | 0.28% | 0.85% | 0.38% | -2.9% | 0.40% | 0.68% | |
| EBITDA Margin | 1.3% | 1.5% | 1.5% | 2.4% | 1.1% | 2.3% | 1.1% | 1.6% | 1.3% | -1.8% | 1.1% | 1.5% | |
| ROA | 2.6% | 3.0% | 4.6% | 12.1% | 2.3% | 3.8% | 1.4% | 4.4% | 2.4% | -9.1% | 1.8% | · |
Liquidity & Solvency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.2 | 1.1 | 1.2 | 1.3 | 1.6 | 1.3 | 1.5 | 1.3 | 1.3 | 1.5 | 1.4 | |
| Quick Ratio | 0.5 | 0.5 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 | 0.5 | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | 1.6 | 3.5 |
Efficiency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 4.9 | 4.7 | 5.0 | 6.3 | 4.9 | 3.1 | 5.0 | 5.3 | 3.7 | 3.2 | 4.4 | 7.7 | |
| Inventory Turnover | 30.6 | 32.5 | 32.2 | 33.0 | 28.0 | 18.2 | 29.7 | 32.6 | 19.1 | 16.9 | 26.8 | 36.8 | |
| Receivables Turnover | 37.0 | 33.5 | 32.0 | 42.4 | 41.5 | 26.0 | 35.0 | 33.7 | 21.3 | 22.5 | 26.8 | 30.2 |
Growth Rates 6
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 8.1% | 4.1% | -12.6% | 42.5% | 59.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -0.56% | 9.0% | 25.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 17.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -11.2% | -27.7% | -57.9% | 495.8% | -40.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -35.3% | 22.0% | 14.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.84% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM) 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $18.56B | $17.16B | $16.49B | $18.88B | $13.25B | $8.32B | $13.08B | $12.67B | $8.92B | $8.24B | $10.31B | $17.27B | |
| Net Income TTM | $98M | $110M | $153M | $362M | $61M | $102M | $36M | $104M | $59M | $-199M | $44M | $117M |
Income Statement 10
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.32B | $4.65B | $4.69B | $4.63B | $4.59B | $4.19B | $4.42B | $4.41B | $4.15B | $4.22B | $3.83B | $4.03B | $4.63B | $5.32B | $4.50B | $3.32B | |
| Cost of Revenue | $4.99B | $4.38B | $4.42B | $4.35B | $4.34B | $3.92B | $4.14B | $4.12B | $3.93B | $3.99B | $3.59B | $3.81B | $4.30B | $5.04B | $4.29B | $3.12B | |
| Gross Profit | $332M | $263M | $271M | $272M | $255M | $269M | $286M | $288M | $215M | $229M | $243M | $222M | $328M | $281M | $206M | $203M | |
| SG&A Expense | $99M | $81M | $76M | $75M | $74M | $79M | $70M | $72M | $70M | $63M | $67M | $62M | $65M | $61M | $56M | $55M | |
| Operating Expenses | $226M | $206M | $210M | $212M | $199M | $211M | $203M | $204M | $189M | $181M | $180M | $171M | $187M | $95M | $153M | $149M | |
| Operating Income | $106M | $57M | $61M | $60M | $56M | $58M | $83M | $84M | $26M | $48M | $63M | $51M | $141M | $187M | $53M | $54M | |
| Pretax Income | $71M | $25M | $29M | $25M | $20M | $24M | $48M | $48M | $-5M | $28M | $42M | $29M | $122M | $166M | $32M | $34M | |
| Income Tax | $839.0K | $392.0K | $-447.0K | $-112.0K | $1M | $148.0K | $2M | $2M | $363.0K | $1M | $691.0K | $400.0K | $11M | $3M | $1M | $386.0K | |
| Net Income | $70M | $25M | $29M | $25M | $19M | $24M | $46M | $46M | $-6M | $27M | $41M | $29M | $111M | $163M | $30M | $34M | |
| EBITDA | $106M | · | $61M | $60M | $56M | · | $83M | $84M | $26M | $48M | $63M | $51M | $141M | $187M | $53M | $54M |
Balance Sheet 20
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables | $773M | $530M | $521M | $564M | $578M | $473M | $472M | $602M | $562M | $521M | $431M | $438M | $430M | $515M | $526M | $361M | |
| Inventory | $736M | $549M | $479M | $496M | $517M | $594M | $499M | $567M | $404M | $391M | $344M | $385M | $428M | $431M | $512M | $413M | |
| Prepaid Expense | $92M | $98M | $82M | $90M | $101M | $92M | $83M | $79M | $88M | $81M | $72M | $79M | $74M | $69M | $78M | $84M | |
| Current Assets | $1.71B | $1.23B | $1.13B | $1.22B | $1.24B | $1.21B | $1.12B | $1.30B | $1.15B | $1.04B | $901M | $951M | $1.00B | $1.08B | $1.20B | $924M | |
| PP&E (Net) | $1.65B | $1.66B | $1.65B | $1.67B | $1.69B | $1.71B | $1.66B | $1.69B | $1.49B | $1.19B | $1.20B | $1.20B | $1.22B | $1.18B | $1.20B | $1.09B | |
| PP&E (Gross) | $2.93B | $2.90B | $2.87B | $2.85B | $2.83B | $2.82B | $2.74B | $2.75B | $2.52B | $2.17B | $2.15B | $2.14B | $2.10B | $2.04B | $2.06B | $1.91B | |
| Accum. Depreciation | $1.28B | $1.24B | $1.21B | $1.18B | $1.14B | $1.11B | $1.08B | $1.06B | $1.03B | $978M | $954M | $932M | $887M | $863M | $860M | $817M | |
| Goodwill | $422M | $422M | $422M | $422M | $422M | $422M | $422M | $426M | $427M | $429M | $428M | $428M | $411M | $410M | $409M | $329M | |
| Intangibles | $12M | $13M | $15M | $16M | $17M | $19M | $19M | $22M | $19M | $21M | $23M | $25M | $29M | $31M | $33M | $29M | |
| Other Non-current Assets | $36M | $38M | $40M | $41M | $41M | $39M | $42M | $42M | $39M | $37M | $44M | $33M | $30M | $30M | $30M | $32M | |
| Total Assets | $4.31B | $3.85B | $3.70B | $3.78B | $3.82B | $3.79B | $3.67B | $3.83B | $3.47B | $3.05B | $2.94B | $2.92B | $2.98B | $3.01B | $3.15B | $2.68B | |
| Accounts Payable | $750M | $573M | $486M | $590M | $520M | $510M | $454M | $558M | $475M | $558M | $399M | $285M | $549M | $574M | $466M | $315M | |
| Accrued Liabilities | $190M | $208M | $167M | $179M | $146M | $223M | $182M | $199M | $148M | $131M | $140M | $115M | $144M | $132M | $105M | $115M | |
| Current Liabilities | $1.52B | $1.08B | $934M | $1.03B | $1.07B | $1.00B | $983M | $1.18B | $986M | $917M | $754M | $773M | $825M | $934M | $908M | $680M | |
| Capital Leases | $298M | $311M | $274M | $262M | $249M | $252M | $263M | $217M | $199M | $209M | $219M | $229M | $232M | $228M | $229M | $223M | |
| Deferred Tax | $65M | $65M | $65M | $60M | $61M | $64M | $64M | $66M | $68M | $66M | $66M | $66M | $65M | $58M | $57M | $56M | |
| Other Non-current Liabilities | $63M | $70M | $68M | $67M | $68M | $77M | $61M | $60M | $57M | $53M | $58M | $53M | $59M | $60M | $55M | $58M | |
| Total Liabilities | $3.60B | $3.18B | $3.02B | $3.10B | $3.12B | $3.07B | $2.94B | $3.12B | $2.70B | $2.28B | $2.16B | $2.17B | $2.23B | $2.34B | $2.62B | $2.14B | |
| AOCI | · | · | · | · | · | · | $457.0K | $-533.0K | $-203.0K | $513.0K | $675.0K | $3.0K | $-7M | $-6M | $-3M | $-66.0K | |
| Liabilities + Equity | $4.31B | $3.85B | $3.70B | $3.78B | $3.82B | $3.79B | $3.67B | $3.83B | $3.47B | $3.05B | $2.94B | $2.92B | $2.98B | $3.01B | $3.15B | $2.68B |
Cash Flow 10
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $3M | $3M | $3M | $3M | $4M | $5M | $4M | $3M | $2M | $2M | $1M | $815.0K | $502.0K | $204.0K | $-48.0K | |
| Amort. of Intangibles | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Operating Cash Flow | $-105M | $101M | $19M | $216M | $-52M | $67M | $123M | $24M | $-183M | $97M | $265M | $-19M | $192M | $363M | $23M | $153M | |
| CapEx | $32M | $39M | $20M | $15M | $18M | $47M | $24M | $16M | $17M | $17M | $22M | $15M | $23M | $25M | $17M | $27M | |
| Investing Cash Flow | $-28M | $-36M | $-20M | $-16M | $-28M | $-47M | $2M | $-231M | $-2M | $-14M | $-96M | $-12M | $-62M | $74M | $-207M | $-37M | |
| Stock Repurchased | · | $3M | $4M | $3M | $532.0K | $3M | $3M | · | · | · | · | · | $0 | · | · | $0 | |
| Net Stock Activity | · | · | · | · | $-532.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $139M | $-71M | $3M | $-192M | $79M | $-33M | $-118M | $148M | $237M | $-83M | $-166M | $34M | $-121M | $-440M | $184M | $-106M | |
| Net Change in Cash | $6M | $-6M | $2M | $9M | $-730.0K | $-12M | $6M | $-59M | $53M | $254.0K | $4M | $3M | $8M | $-3M | $-15.0K | $9M | |
| Free Cash Flow | $-137M | · | · | · | $-69M | · | · | · | $-199M | · | · | $-35M | · | · | $6M | · |
Profitability 6
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 6.2% | · | 5.8% | 5.9% | 5.6% | · | 6.5% | 6.5% | 5.2% | 5.4% | 6.3% | 5.5% | 7.1% | 5.3% | 4.6% | 6.1% | |
| Operating Margin | 2.0% | · | 1.3% | 1.3% | 1.2% | · | 1.9% | 1.9% | 0.62% | 1.1% | 1.6% | 1.3% | 3.0% | 3.5% | 1.2% | 1.6% | |
| Net Margin | 1.3% | · | 0.62% | 0.54% | 0.41% | · | 1.0% | 1.1% | -0.14% | 0.64% | 1.1% | 0.72% | 2.4% | 3.1% | 0.68% | 1.0% | |
| Pretax Margin | 1.3% | · | 0.61% | 0.54% | 0.43% | · | 1.1% | 1.1% | -0.13% | 0.66% | 1.1% | 0.73% | 2.6% | 3.1% | 0.70% | 1.0% | |
| EBITDA Margin | 2.0% | · | 1.3% | 1.3% | 1.2% | · | 1.9% | 1.9% | 0.62% | 1.1% | 1.6% | 1.3% | 3.0% | 3.5% | 1.2% | 1.6% | |
| ROA | 1.7% | · | 0.79% | 0.66% | 0.51% | · | 1.4% | 1.4% | -0.18% | 0.89% | 1.4% | 0.96% | 3.9% | 5.7% | 1.0% | 1.3% |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | · | 1.2 | 1.2 | 1.2 | · | 1.1 | 1.1 | 1.2 | 1.1 | 1.2 | 1.2 | 1.2 | 1.2 | 1.3 | 1.4 | |
| Quick Ratio | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.6 | 0.5 |
Efficiency 3
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.3 | · | 1.3 | 1.2 | 1.3 | · | 1.3 | 1.3 | 1.3 | 1.4 | 1.3 | 1.3 | 1.6 | 1.9 | 1.5 | 1.3 | |
| Inventory Turnover | 8.0 | · | 9.0 | 8.2 | 9.4 | · | 9.3 | 9.1 | 10.0 | 9.8 | 9.3 | 8.5 | 10.2 | 10.9 | 8.8 | 8.4 | |
| Receivables Turnover | 7.9 | · | 9.5 | 7.9 | 8.1 | · | 8.9 | 8.5 | 8.3 | 8.9 | 8.1 | 8.4 | 11.7 | 12.3 | 10.7 | 11.1 |
Valuation (TTM) 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $19.24B | · | $18.34B | $18.05B | $17.57B | · | $17.20B | $16.61B | $16.23B | $16.71B | $17.81B | $18.48B | $17.77B | $16.43B | $13.66B | $11.35B | |
| Net Income TTM | $143M | · | $119M | $136M | $105M | · | $113M | $109M | $92M | $209M | $345M | $334M | $338M | $239M | $72M | $46M |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $18.56B | $17.16B | $16.49B | $18.88B | $13.25B |
| Gross Margin % | 5.7% | 6.2% | 5.9% | 5.8% | 5.4% |
| Operating Margin % | 1.3% | 1.5% | 1.5% | 2.4% | 1.1% |
| Net Income | $98M | $110M | $153M | $362M | $61M |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.2 | 1.1 | 1.2 | 1.3 |
| Quick Ratio | 0.5 | 0.5 | 0.6 | 0.5 | 0.5 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $193M | $-72M | $424M | $373M | $-51M |
Latest News Recent headlines mentioning this company
- Is Kailera Therapeutics a Buy After Its Sizzling IPO?
- Is Eli Lilly and Company (LLY) A Good Stock To Buy Now?
- Dole plc Q1 2026 Earnings Call Summary
- Is This News From Novo Nordisk a Warning for Eli Lilly Shareholders?
- Becton, Dickinson and Company Q2 2026 Earnings Call Summary
- Is Eli Lilly Stock Heading for $1,000?
- Jim Cramer Praises Eli Lilly’s Performance
- Smoothie King plots expansion as wellness trends boost sales
- Is Pfizer's 6% Dividend Yield Safe? Here's What Investors Need to Know.
- A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.